Market Research Logo

BMI Special Report Advances in the Biosimilars and Injectable Generics Market 2015

BMI Special Report Advances in the Biosimilars and Injectable Generics Market 2015

The injectable generics sector has been through a sustained period of consolidation over the last few years as the leading companies have increased their presence through acquisition. Interest in this specialist sector has come from both established generic manufacturers and major pharmaceutical companies. Among the most significant changes in recent months has been Pfizer’s acquisition of Hospira, which has provided the company with a world leading position in generic injectables and significant experience in the European biosimilars market. Other major players in the market include Sandoz (Novartis), Hikma Pharmaceuticals, Fresenius Kabi and Teva Pharmaceutical Industries.


FOREWORD
EXECUTIVE SUMMARY
MARKET OVERVIEW
Market Size
Generic and Biosimilar Opportunities
Major Players
CANCER
Hormonal Therapies
Faslodex (fulvestrant)
Zoladex (goserelin)
Chemotherapy
Abraxane (paclitaxel formulated as albumin-bound nanoparticles, or nab-paclitaxel)
Alimta (pemetrexed)
Velcade (bortezomib)
Monoclonal Antibodies
MabThera/Rituxan (rituximab)
Herceptin (trastuzumab)
Avastin (bevacizumab)
Erbitux (cetuximab)
Supportive Therapies
G-CSF
Neupogen (filgrastim)
Neulasta (pegfilgrastim)
DIABETES
Humulin (insulin [rDNA origin])
Humalog (insulin lispro)
Lantus (insulin glargine)
Apidra (insulin glulisine)
Levemir (insulin detemir)
NovoRapid & NovoMix (insulin aspart)
HAEMATOLOGY
Epogen/Eprex/Procrit (epoetin alfa)
ii January 2016
Aranesp (darbepoetin alfa)
Lovenox/Clexane (enoxaparin)
IMMUNOLOGY
Multiple Sclerosis
Copaxone (glatiramer acetate)
Avonex (interferon beta-1a)
Rebif (interferon beta-1a)
Betaferon/Betaseron & Extavia (interferon beta-1b)
Biosimilar Interferon Beta
Tysabri (natalizumab)
Rheumatoid Arthritis
Enbrel (etanercept)
Humira (adalimumab)
Remicade (infliximab)
INFECTION
Cubicin (daptomycin)
Invanz (ertapenem)
Tygacil (tigecycline)
Synagis (palivizumab)
PegIntron (peginterferon alfa-2b)
Pegasys (pegylated-40K interferon alfa-2a)
Biosimilar Interferon Alfa
COMPANY PROFILES
Allergan/Actavis
Overview
Products
Major Developments
Akorn
Overview
Products
American Regent
Overview
Products
Amphastar Pharmaceuticals
Overview
Products
Apotex
Overview
Products
Aurobindo Pharma
Overview
Products
Claris
Overview
Products
Dr Reddy’s Laboratories
Overview
Products
Fresenius Kabi
Overview
Products
Hikma Pharmaceuticals
Overview
Products
Hospira (Pfizer)
Overview
Products
Litigation
Mylan
Overview
Products
Sagent Pharmaceuticals
Overview
Products
Sandoz
Overview
Products
Litigation
Sun Pharma
Overview
Products
Teva Pharmaceutical Industries
Overview
Products
Wockhardt
Products
Appendix: FDA ANDA Approvals
Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report